Medication info
Telmisartan Plus Tablet 80/12.5 mg

Telmisartan Plus Tablet 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
White or almost white, double-convex round tablet
Packaging
30 tablets/box[(10 tablets/PTP × 3)], 30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201902334 · Approved 2019.04.16 · Insurance code 694002310

Summary

Main use
Treatment of essential hypertension inadequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Older adults No dosage adjustment is necessary.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension where blood pressure cannot be effectively controlled with telmisartan alone. It helps to effectively lower blood pressure and reduce the risk of cardiovascular diseases. Therefore, this medication is administered to improve symptoms for blood pressure management.

How to take

Adult dose

Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, switching directly from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Older adults No dosage adjustment is necessary.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication should not be taken during pregnancy, especially in the second and third trimesters, as it can pose serious risks to the fetus and newborn. It should not be administered to patients with allergies to the components in this medication or those with specific liver or kidney diseases. Caution is advised when used in elderly patients or those with elevated potassium levels or impaired liver function. The hydrochlorothiazide component may cause electrolyte imbalances in the body, so serum electrolyte levels should be monitored regularly during treatment. During the use of this medication, side effects such as dizziness, hypotension, gastrointestinal disturbances, and skin rashes may occur, and if abnormal symptoms appear, immediate consultation with a healthcare provider is necessary. Interactions may occur if this medication is taken with other antihypertensives, diuretics, lithium, or non-steroidal anti-inflammatory drugs, so be sure to inform your healthcare provider of any other medications being taken. Women who are pregnant or planning to become pregnant should avoid taking this medication, and it is also considered safe to refrain from taking it while breastfeeding. In case of overdose, symptoms such as hypotension, electrolyte disturbances, and dehydration may occur, requiring immediate medical attention. This medication is not recommended for children as safety and efficacy have not been established in the pediatric population. Drowsiness or dizziness may occur while taking this medication, so caution is advised when driving or operating machinery. Store this medication away from direct sunlight and in a dry place, out of reach of children.

Side effects

  • bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 121 more
  • dizziness
  • fainting
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver function abnormalities
  • liver disorders
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle cramps
  • myalgia
  • arthralgia
  • pain in extremities
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased serum creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylaxis
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disturbances
  • eczema
  • drug rash
  • toxic epidermal necrolysis
  • bone pain
  • renal dysfunction
  • myasthenia
  • influenza-like illness
  • increased serum creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • aplastic anemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • myasthenia
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • pruritus
  • myalgia
  • buoyancy
  • lip and hand tremors
  • sensory hypersensitivity
  • visual impairment
  • hypotension
  • tachycardia
  • hypokalemia
  • hypochloremia
  • dehydration
  • nausea
  • somnolence

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius to ensure the medication's efficacy and safety are preserved.

Appearance and packaging

Appearance

White or almost white, double-convex round tablet

Package unit

30 tablets/box[(10 tablets/PTP × 3)], 30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.